Abstract
Amarin’s icosapent ethyl (Vascepa) is FDA approved to treat extremely high triglyceride values of 500 mg/dL or above. Although physicians commonly prescribe the medication for offlabel use, the agreement would allow Amarin to market Vascepa to patients with high triglyceride levels of 200 mg/ dL to 499 mg/dL. “This is concerning to me because ef cacy has not yet been clearly established for this purpose,” said Joseph Saseen, PharmD, BCPS, BCACP, vice chair of the department of clinical pharmacy at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
